litlas
ログインアカウント作成

Ivan Borrello

1988–2025 年に発表

64
論文数
19,950
被引用数
52
h 指数
63
i10 指数

被引用数

Ivan Borrello の年別被引用数1979 年: 被引用 1 件1988 年: 被引用 3 件1989 年: 被引用 10 件1990 年: 被引用 19 件1991 年: 被引用 12 件1992 年: 被引用 14 件1993 年: 被引用 6 件1994 年: 被引用 11 件1995 年: 被引用 10 件1996 年: 被引用 7 件1997 年: 被引用 12 件1998 年: 被引用 14 件1999 年: 被引用 30 件2000 年: 被引用 43 件2001 年: 被引用 39 件2002 年: 被引用 48 件2003 年: 被引用 47 件2004 年: 被引用 53 件2005 年: 被引用 42 件2006 年: 被引用 69 件2007 年: 被引用 110 件2008 年: 被引用 154 件2009 年: 被引用 175 件2010 年: 被引用 176 件2011 年: 被引用 182 件2012 年: 被引用 182 件2013 年: 被引用 200 件2014 年: 被引用 178 件2015 年: 被引用 326 件2016 年: 被引用 345 件2017 年: 被引用 332 件2018 年: 被引用 328 件2019 年: 被引用 813 件2020 年: 被引用 875 件2021 年: 被引用 823 件2022 年: 被引用 531 件2023 年: 被引用 410 件2024 年: 被引用 524 件2025 年: 被引用 212 件2026 年: 被引用 5 件1980〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,916 件、この内訳の 30.2%中国: 引用元論文 975 件、この内訳の 10.1%ドイツ: 引用元論文 596 件、この内訳の 6.2%イタリア: 引用元論文 564 件、この内訳の 5.8%フランス: 引用元論文 470 件、この内訳の 4.9%イギリス: 引用元論文 453 件、この内訳の 4.7%日本: 引用元論文 336 件、この内訳の 3.5%スペイン: 引用元論文 324 件、この内訳の 3.3%カナダ: 引用元論文 265 件、この内訳の 2.7%オランダ: 引用元論文 263 件、この内訳の 2.7%オーストラリア: 引用元論文 183 件、この内訳の 1.9%スイス: 引用元論文 181 件、この内訳の 1.9%
0%30.2%その他 22.1%

機関

分野

  • Medicine61.9%
  • Immunology and Microbiology26.8%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Neuroscience0.7%
  • Engineering0.6%
  • Computer Science0.2%
  • その他0.7%

トピック

  • Cancer Immunotherapy and Biomarkers9.6%
  • Immune Cell Function and Interaction8%
  • Immunotherapy and Immune Responses6.3%
  • Immune cells in cancer6.2%
  • CAR-T cell therapy research5.8%
  • Hematopoietic Stem Cell Transplantation4.6%
  • その他59.5%

共著者

全論文

検索で開く
  1. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

    著者: Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C. Scott, Martin Gutierrez, Stephen J. Schuster, Michael Millenson, Deepika Cattry, Gordon J. Freeman, Scott J. Rodig, Bjoern Chapuy, Azra H. Ligon, Lili Zhu, Joseph F. Grosso, Su Young Kim, John M. Timmerman, Margaret A. Shipp, Philippe Armand - New England Journal of Medicine 2014 被引用: 3,547

  2. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    著者: Leo Luznik, Paul V. O’Donnell, Heather J. Symons, Allen Chen, M. Susan Leffell, Marianna Zahurak, Ted Gooley, S Piantadosi, Michele Kaup, Richard F. Ambinder, Carol Ann Huff, William Matsui, Javier Bolaños‐Meade, Ivan Borrello, Jonathan D. Powell, Elizabeth B. Harrington, S. Warnock, Mary E.D. Flowers, Robert A. Brodsky, Brenda M. Sandmaier, Rainer Storb, Richard J. Jones, Ephraim J. Fuchs - Biology of Blood and Marrow Transplantation 2008 被引用: 1,906

  3. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

    著者: Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma Scott, Ahmad Halwani, Martin Gutierrez, Michael Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav V. Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Scott J. Rodig, Deepika Cattry, Lili Zhu, Joseph F. Grosso, M. Brigid Garelik, Margaret A. Shipp, Ivan Borrello, John M. Timmerman - Journal of Clinical Oncology 2016 被引用: 1,011

  4. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

    著者: Paolo Serafini, Kristen F. Meckel, Michael J. Kelso, Kimberly Noonan, Joseph A. Califano, Wayne M. Koch, Luigi Dolcetti, Vincenzo Bronte, Ivan Borrello - The Journal of Experimental Medicine 2006 被引用: 754

  5. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

    著者: Rajani Ravi, Kimberly Noonan, Vui Pham, Rishi Bedi, Alex Zhavoronkov, Ivan V. Ozerov, Eugene Makarev, Artem V. Artemov, Piotr Wysocki, Ranee Mehra, Sridhar Nimmagadda, Luigi Marchionni, David Sidransky, Ivan Borrello, Evgeny Izumchenko, Atul Bedi - Nature Communications 2018 被引用: 329

  6. CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity

    著者: Meisam Naeimi Kararoudi, Yuya Nagai, Ezgi Elmas, Marcelo de Souza Fernandes Pereira, Syed Abbas Ali, Philip Imus, Darren Wethington, Ivan Borrello, Dean A. Lee, Gabriel Ghiaur - Blood 2020 被引用: 126

  7. Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells

    著者: Paolo Serafini, Stephanie Mgebroff, Kimberly Noonan, Ivan Borrello - Cancer Research 2008 被引用: 665

  8. Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma

    著者: Donald T. Weed, Jennifer L. Vella, Isildinha M. Reis, Adriana C. De La Fuente, Carmen Gómez, Zoukaa Sargi, Ronen Nazarian, Joseph A. Califano, Ivan Borrello, Paolo Serafini - Clinical Cancer Research 2014 被引用: 256

  9. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

    著者: Christiane Meyer, Alexandra Sevko, Marcel Ramacher, Alexandr V. Bazhin, Christine S. Falk, Wolfram Osen, Ivan Borrello, Masashi Kato, Dirk Schadendorf, Michal Baniyash, Viktor Umansky - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 被引用: 342

  10. Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

    著者: Joseph A. Califano, Zubair Khan, Kimberly Noonan, Lakshmi Rudraraju, Zhe Zhang, Hao Wang, Steven N. Goodman, Christine G. Gourin, Patrick K. Ha, Carole Fakhry, John Saunders, Marshall Levine, Mei San Tang, Geoffrey Neuner, Jeremy D. Richmon, Ray Blanco, Nishant Agrawal, Wayne M. Koch, Shanthi Marur, Donald T. Weed, Paolo Serafini, Ivan Borrello - Clinical Cancer Research 2015 被引用: 184

  11. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

    著者: Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak, Allen Chen, B. Douglas Smith, Robert A. Brodsky, Carol Ann Huff, Ivan Borrello, William Matsui, Jonathan D. Powell, Yvette L. Kasamon, Steven N. Goodman, Allan D. Hess, Hyam I. Levitsky, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs - Blood 2010 被引用: 404

  12. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

    著者: Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina D. Wagner‐Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños‐Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky - Blood Advances 2020 被引用: 149

  13. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

    著者: Giovanna Gallina, Luigi Dolcetti, Paolo Serafini, Carmela De Santo, Ilaria Marigo, Mario P. Colombo, Giuseppe Basso, Frank Brombacher, Ivan Borrello, Paola Zanovello, Silvio Bicciato, Vincenzo Bronte - Journal of Clinical Investigation 2006 被引用: 785

  14. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

    著者: Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Hua-Ling Tsai, Javier Bolaños‐Meade, Gary L. Rosner, Christopher G. Kanakry, Karlo Perica, Heather J. Symons, Robert A. Brodsky, Douglas E. Gladstone, Carol Ann Huff, Keith W. Pratz, Gabrielle T. Prince, Amy E. DeZern, Ivana Gojo, William Matsui, Ivan Borrello, Michael A. McDevitt, Lode J. Swinnen, B. Douglas Smith, Mark J. Levis, Richard F. Ambinder, Leo Luznik, Richard J. Jones, Ephraim J. Fuchs, Yvette L. Kasamon - Blood 2015 被引用: 300

  15. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

    著者: Yvette L. Kasamon, Javier Bolaños‐Meade, Gabrielle T. Prince, Hua-Ling Tsai, Shannon R. McCurdy, Jennifer A. Kanakry, Gary L. Rosner, Robert A. Brodsky, Karlo Perica, B. Douglas Smith, Douglas E. Gladstone, Lode J. Swinnen, Margaret M. Showel, William Matsui, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Michael A. McDevitt, Ivana Gojo, Amy E. DeZern, Satish Shanbhag, Mark J. Levis, Leo Luznik, Richard F. Ambinder, Ephraim J. Fuchs, Richard J. Jones - Journal of Clinical Oncology 2015 被引用: 239

  16. Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression

    著者: Paolo Serafini, Ivan Borrello, Vincenzo Bronte - Seminars in Cancer Biology 2005 被引用: 763

  17. A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies

    著者: Philippe Armand, Alexander M. Lesokhin, Ivan Borrello, John M. Timmerman, Martin Gutierrez, Lili Zhu, Mihaela Popa McKiver, Stephen M. Ansell - Leukemia 2020 被引用: 110

  18. High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells

    著者: Paolo Serafini, Rebecca Carbley, Kimberly Noonan, Gladys Tan, Vincenzo Bronte, Ivan Borrello - Cancer Research 2004 被引用: 515

  19. A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

    著者: Kimberly Noonan, Luigi Marchionni, Judy M. Anderson, Drew M. Pardoll, G. David Roodman, Ivan Borrello - Blood 2010 被引用: 209

  20. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

    著者: Kevin F. Staveley-O’Carroll, Eduardo M. Sotomayor, Jami Montgomery, Ivan Borrello, Leon Hwang, Steve Fein, Drew M. Pardoll, Hyam I. Levitsky - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 被引用: 696

  21. Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

    著者: William Matsui, Qiuju Wang, James Barber, Sarah Brennan, B. Douglas Smith, Ivan Borrello, Ian McNiece, Lan Lin, Richard F. Ambinder, Craig D. Peacock, D. Neil Watkins, Carol Ann Huff, Richard J. Jones - Cancer Research 2008 被引用: 538

  22. Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting

    著者: Vasileios Karantalis, Darcy L. DiFede, Gary Gerstenblith, Si M. Pham, James F. Symes, Juan P. Zambrano, Joel E. Fishman, Pradip M. Pattany, Ian McNiece, John V. Conte, Steven P. Schulman, Kathérine C. Wu, Ashish S. Shah, Elayne Breton, Janice Davis‐Sproul, Richard P. Schwarz, Gary Feigenbaum, Muzammil Mushtaq, Viky Y. Suncion, Albert C. Lardo, Ivan Borrello, Adam Mendizabal, Tomer Z. Karas, John Byrnes, Maureen H. Lowery, Alan W. Heldman, Joshua M. Hare - Circulation Research 2014 被引用: 350

  23. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide

    著者: Shannon R. McCurdy, Yvette L. Kasamon, Christopher G. Kanakry, Javier Bolaños‐Meade, Hua-Ling Tsai, Margaret M. Showel, Jennifer A. Kanakry, Heather J. Symons, Ivana Gojo, B. Douglas Smith, Maria Bettinotti, William Matsui, Amy E. DeZern, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Douglas E. Gladstone, Lode J. Swinnen, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik - Haematologica 2016 被引用: 188

  24. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial

    著者: Javier Bolaños‐Meade, Kenneth R. Cooke, Christopher Gamper, Syed Abbas Ali, Richard F. Ambinder, Ivan Borrello, Ephraim J. Fuchs, Douglas E. Gladstone, Christian B. Gocke, Carol Ann Huff, Leo Luznik, Lode J. Swinnen, Heather J. Symons, Stephanie A. Terezakis, Nina D. Wagner‐Johnston, Richard J. Jones, Robert A. Brodsky - The Lancet Haematology 2019 被引用: 154